You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

intensive chemotherapy

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Triple Negative Breast Cancer Trial in Houston (L-NMMA, Docetaxel, Amlodipine)

Completed
  • Metastatic Triple Negative Breast Cancer
  • Houston, Texas
    Houston Methodist Hospital
Oct 12, 2021

Metastatic Colorectal Cancer Trial in France (Aflibercept-FOLFIRI)

Terminated
  • Metastatic Colorectal Cancer
  • Bordeaux, France
  • +7 more
Oct 19, 2021

Breast Cancer Stage, Insulin Resistance, Racial Bias Trial in Baton Rouge (Metformin Extended Release Oral Tablet)

Suspended
  • Breast Cancer Stage
  • +2 more
  • Metformin Extended Release Oral Tablet
  • Baton Rouge, Louisiana
    Woman's Hospital
Nov 15, 2021

Hodgkins Lymphoma Trial in Cologne (Rituximab, BEACOPP escalated)

Completed
  • Hodgkins Lymphoma
  • Cologne, Germany
    1st Dept. of Medicine, Cologne University Hospital
Nov 11, 2020

Chemo-Induced Peripheral Neuropathy, Malignant Tumor Trial in Houston (Quality-of-Life Assessment, Questionnaire Administration,

Withdrawn
  • Chemotherapy-Induced Peripheral Neuropathy
  • Malignant Neoplasm
  • Quality-of-Life Assessment
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 11, 2020

Nociceptive Pain Trial (Skin conductance guided antinociception, Standard care antinociception)

Not yet recruiting
  • Nociceptive Pain
  • Skin conductance guided antinociception
  • Standard care antinociception
  • (no location specified)
Feb 1, 2021

Cutaneous Neurofibroma Trial in Copenhagen, Gothenburg (TOOsonix System ONE-M)

Active, not recruiting
  • Cutaneous Neurofibroma
  • TOOsonix System ONE-M
  • Copenhagen, Hovedstaden, Denmark
  • +1 more
Jun 23, 2022

Cancer of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Cancer of the Stomach Trial in Philadelphia

Completed
Has Results
  • Cancer of the Esophagus
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 4, 2021

Hodgkin Lymphoma Trial in Saint Petersburg, Irkutsk (Nivolumab, Ifosfamide, Carboplatin)

Recruiting
  • Hodgkin Lymphoma
  • Saint Petersburg, Pesochny, Russian Federation
  • +2 more
Jul 19, 2021

Esophageal Cancer Trial in Philadelphia (18F-FDG (Fluorodeoxyglucose) PET, Carboplatin, Paclitaxel)

Active, not recruiting
  • Esophageal Cancer
  • 18F-FDG (Fluorodeoxyglucose) PET
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Sep 27, 2021

Severity in Patients With COVID-19

Completed
  • COVID-19
  • routine laboratory tests
  • Zagazig, Asharqia, Egypt
    Zagazig University Faculty of medicine Chest Department
Feb 8, 2022

Selective Mutism Trial in Miami (Remote Caregiver Training, Remote Intensive Group Behavioral Treatment (IGBT))

Completed
  • Selective Mutism
  • Remote Caregiver Training
  • Remote Intensive Group Behavioral Treatment (IGBT)
  • Miami, Florida
    Florida International University
Dec 14, 2020

Pancreatic Ductal Adenocarcinoma Trial in Italy (PAXG regimen (cisplatin, nab-paclitaxel, capecitabine, gemcitabine) chemo)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • PAXG regimen (cisplatin, nab-paclitaxel, capecitabine, gemcitabine) chemotherapy
  • Aviano, Italy
  • +29 more
Feb 8, 2021

NSCLC Metastatic Trial in Seoul (Lazertinib, Tepotinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Seoul, Gangnam-gu, Korea, Republic of
    Samsung Medical Center
Oct 27, 2023

Type 1 Diabetes Trial in Montréal (Induced-hypoglycemia test)

Completed
  • Type 1 Diabetes
  • Induced-hypoglycemia test
  • Montréal, Canada
    Institut de recherches cliniques de Montréal
Sep 16, 2020

Bladder Cancer, Urethral Cancer, Urachal Cancer Trial in Houston (5-Fluorouracil (5-FU), Leucovorin, Cisplatin)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • 5-Fluorouracil (5-FU)
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 18, 2021

Parenteral Nutrition Associated Liver Disease Trial in Nashville (Omegaven)

Completed
Has Results
  • Parenteral Nutrition Associated Liver Disease
  • Nashville, Tennessee
    Monroe Carell Jr Children's Hospital at vanderbilt
Dec 11, 2020

Delirium in Critically Ill Children: a Qualitative Study

Recruiting
  • Delirium
    • Hamilton, Ontario, Canada
      McMaster University
    Feb 23, 2021

    Cognitive and Brain Function of Breast Cancer Patients

    Unknown status
    • Breast Cancer
      • Singapore, Singapore
        Nationa University Hospital
      Sep 30, 2020

      Exploiting Gut Microbiota and Its Metabolites in Pelvic Cancer

      Not yet recruiting
      • Pelvic Neoplasm
      • Faecal microbiota sampling and blood sampling
      • Aberdeen, Scotland, United Kingdom
        Aberdeen Royal Infirmary
      Oct 28, 2022

      Biliary Tract Cancer Trial in Wuhan (Nab-paclitaxel + Cisplatin, Gemcitabine + Cisplatin)

      Recruiting
      • Biliary Tract Cancer
      • Nab-paclitaxel + Cisplatin
      • Gemcitabine + Cisplatin
      • Wuhan, Hubei, China
        Tongji Hospital, Tongji Medical College, Huazhong University of
      Dec 29, 2020

      Tumor Malignant, Breast Cancer, Ovarian Cancer Trial in Leiden (Shorter PICT)

      Completed
      • Neoplasm Malignant
      • +2 more
      • Shorter PICT
      • Leiden, Netherlands
        LUMC
      Mar 30, 2021

      NSCLC Trial in Worldwide (ASA404, Placebo, carboplatin)

      Terminated
      • Non-Small Cell Lung Cancer
      • Mobile, Alabama
      • +248 more
      Dec 16, 2020

      Spatial Orientation, Balance Trial in Magdeburg (Training)

      Completed
      • Spatial Orientation
      • Balance
      • Training
      • Magdeburg, Sachsen-Anhalt, Germany
        DZNE
      Jul 21, 2020

      Gastric Carcinoma Stage IV, Esophagogastric Junction Adenocarcinoma Stage IV Trial in Moscow (Irinotecan, Oxaliplatin, 5-FU)

      Recruiting
      • Gastric Carcinoma Stage IV
      • Esophagogastric Junction Adenocarcinoma Stage IV
      • Moscow, Russian Federation
        Blokhin's Russian Cancer Research Center
      Apr 11, 2021